American Journal of Ophthalmology
Volume 143, Issue 2 , Pages 335-338, February 2007

Anti-VEGF Bevacizumab (Avastin®) for Radiation Optic Neuropathy

  • Paul T. Finger, MD

      Affiliations

    • Corresponding Author InformationInquiries to Paul T. Finger, MD, The New York Eye Cancer Center, 115 East 61st Street, New York City, New York, 10021

New York Eye Cancer Center, New York, New York.

Accepted 1 September 2006. published online 23 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported in part by a Grant from John and Myrna Daniels, Toronto, Ontario, Canada, and The EyeCare Foundation, New York, New York. The author indicates no financial conflict of interest. The author was involved in collection, management, analysis and interpretation of data, and preparation of the data and revision including references; involved in collection of data; and involved in management, statistical analysis and interpretation of the data, and preparation of the manuscript.

PII: S0002-9394(06)01067-1

doi:10.1016/j.ajo.2006.09.014

American Journal of Ophthalmology
Volume 143, Issue 2 , Pages 335-338, February 2007

Article Tools

* Image Usage & Resolution